Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Praprotnik

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|August 14, 2008
Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?N Gaspersic, I Sersa, V Jevtic, et al.
Annals of the Rheumatic Diseases|July 17, 2009
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritisP Bohanec Grabar, B Rozman, D Logar, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Parasympathetic nervous system dysfunction in primary Sjögren's syndromeA Hocevar, M Tomsic, S Praprotnik, et al.
Arthritis and Rheumatism|July 24, 2001
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implicationsS Praprotnik, M Blank, P L Meroni, et al.
Rheumatology (Oxford, England)|December 2, 2005
Leflunomide-associated tuberculosis?A Hocevar, B Rozman, S Praprotnik, et al.
Wiener Klinische Wochenschrift|October 6, 2000
Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesisJ Jeruc, V Jurcić, A Vizjak, et al.
International Immunology|February 7, 2001
Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cellsS Praprotnik, M Blank, Y Levy, et al.
Annals of the Rheumatic Diseases|May 15, 2002
Leflunomide and hypertensionB Rozman, S Praprotnik, D Logar, et al.
The Israel Medical Association Journal : IMAJ|May 10, 2001
Pathogenic anti-endothelial cell antibodies: classification to anti-microvascular EC and anti-macrovascular EC antibodiesY Shoenfeld, S Praprotnik, Y Levy, et al.
American Journal of Hypertension|March 13, 2001
Autoantibodies to oxidized low-density lipoprotein in coronary artery diseaseY Sherer, A Tenenbaum, M Blank, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|August 14, 2008
Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?N Gaspersic, I Sersa, V Jevtic, et al.
Annals of the Rheumatic Diseases|July 17, 2009
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritisP Bohanec Grabar, B Rozman, D Logar, et al.
Annals of the Rheumatic Diseases|July 16, 2003
Parasympathetic nervous system dysfunction in primary Sjögren's syndromeA Hocevar, M Tomsic, S Praprotnik, et al.
Arthritis and Rheumatism|July 24, 2001
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implicationsS Praprotnik, M Blank, P L Meroni, et al.
Rheumatology (Oxford, England)|December 2, 2005
Leflunomide-associated tuberculosis?A Hocevar, B Rozman, S Praprotnik, et al.
Wiener Klinische Wochenschrift|October 6, 2000
Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesisJ Jeruc, V Jurcić, A Vizjak, et al.
International Immunology|February 7, 2001
Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cellsS Praprotnik, M Blank, Y Levy, et al.
Annals of the Rheumatic Diseases|May 15, 2002
Leflunomide and hypertensionB Rozman, S Praprotnik, D Logar, et al.
The Israel Medical Association Journal : IMAJ|May 10, 2001
Pathogenic anti-endothelial cell antibodies: classification to anti-microvascular EC and anti-macrovascular EC antibodiesY Shoenfeld, S Praprotnik, Y Levy, et al.
American Journal of Hypertension|March 13, 2001
Autoantibodies to oxidized low-density lipoprotein in coronary artery diseaseY Sherer, A Tenenbaum, M Blank, et al.
Pageof 4